Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
18 déc. 2024 08h18 HE
|
Quoin Pharmaceuticals, Inc.
Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
17 déc. 2024 17h24 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their...
SKYX Collaborates with JIT Electrical Supply, Leading Builder Supplier of Electrical, Lighting and Ceiling Fan Products
17 déc. 2024 09h15 HE
|
SKYX Platforms Corp.
SKYX Collaborates with JIT Electrical Supply, Leading Builder Supplier of Electrical, Lighting and Ceiling Fan Products
AmpliTech Group Announces Pricing of $3.1 Million Registered Direct Offering
17 déc. 2024 09h15 HE
|
AmpliTech Group, Inc.
AmpliTech Group Announces Pricing of $3.1 Million Registered Direct Offering
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
17 déc. 2024 06h30 HE
|
Silexion Therapeutics Corp
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Sezzle and Bealls Inc. Join Forces to Transform Holiday Shopping with Smarter Spending
16 déc. 2024 08h38 HE
|
Sezzle
Minneapolis, MN, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ: SEZL) (Sezzle or Company) // - Sezzle, a leader in the flexible payments industry, is thrilled to announce its partnership...
SUNation Energy to Ring the Nasdaq Closing Bell on December 16, 2024
16 déc. 2024 08h15 HE
|
SUNation Energy, Inc.
SUNation Energy, Inc. will be ringing the NASDAQ closing bell on Monday, December 16.
Totaligent, Inc. Successfully Completes PCAOB Audits for 2022 and 2023; Resumes SEC Reporting as a Voluntary Filer
16 déc. 2024 08h05 HE
|
Totaligent, Inc.
Totaligent (OTC: TGNT) completed its PCAOB audits for the fiscal years 2022 and 2023, and resumed SEC voluntary filer reporting financials through Q3 2024
Xeriant Engages Leading Investor Relations and Performance Marketing Firms to Enhance Shareholder Communication and Public Awareness
16 déc. 2024 08h05 HE
|
Xeriant, Inc.
Xeriant (OTCQB: XERI) engages 247MarketNews for comprehensive investor relations services and AdVenture Media Group for targeted performance marketing
Kraig Biocraft Laboratories Recaps Year of Breakthrough Achievements with BAM-1 Hybrids
16 déc. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) reflects on a year of extraordinary progress for its groundbreaking BAM-1 hybrids—the world's first commercially viable silkworms